Delivers up-to-date industry news on topics like drug approvals, product recalls, company expansions and acquisitions, market trends for all OSD forms, as well as excipients, packaging and supply chain issues. Monitors market trends in specific drug categories as well as in supplements/nutraceuticals. Provides updates on clinical trials. Includes alerts about new or upcoming regulatory issues.
Endo, Inc. announced the launch of tiopronin delayed-release tablets, a generic version of Travere Therapeutics' THIOLA EC®.
read more
Akebia Therapeutics®, Inc. announced key updates pertaining to the commercial launch of Vafseo® (vadadustat) Tablets.
"Since Vafseo approval in late March, our team has worked diligently on commercial launch activities to drive prescriber demand with the goal to optimize Vafseo's revenue ramp during the two-year Transitional Drug Add-on Payment ...
read more
Cosette Pharmaceuticals, Inc. has completed the acquisition of Ambien® and Ambien CR® in the United States from Sanofi US.
read more
dsm-firmenich has announced the launch of CBtru® – an advanced formulated cannabidiol (CBD) drug product intermediate designed for oral solid delivery formats.
read more
YARAL Pharma Inc. , the U.S. generics subsidiary of IBSA (Institut Biochimique SA), a multinational pharmaceutical company headquartered in Lugano, Switzerland, announced that they are now the exclusive supplier of the authorized generic levothyroxine sodium capsules in the United States.
read more
American Health Packaging on behalf of BluePoint Laboratories is voluntarily recalling 21 batches of Potassium Chloride Extended-Release Capsules, USP (750 mg) 10 mEq K, to the consumer level.
read more
Hovione has announced the opening of a state-of-the-art continuous tableting (CT) line at its R&D Center in Lisbon.
read more
RSSL announced the launch of its new dietary supplement testing service to support clients across R&D, manufacturing, and supply chain functions to meet regulatory and quality requirements with efficiency and ease.
read more
ChemWerth, a supplier of generic active pharmaceutical ingredients (APIs), announced that company founder Peter J. Werth has stepped down as president and CEO to spend more time on his entrepreneurial ventures and many philanthropic efforts, effective immediately.
read more
Positive results from the ECHO Phase III trial showed AstraZeneca’s CALQUENCE® (acalabrutinib) in combination with bendamustine and rituximab demonstrated a statistically
read more
Freudenberg Medical, a global contract design and manufacturing (CDMO) partner to the medical device and biopharma industry with facilities in key industry hubs across the Americas, Europe and Asia, announced plans to further expand its drug device combination products business.
read more
According to a new market research report titled, "Pharmaceutical Processing and Packaging Equipment Market Size, Share, Forecast, & Trends Analysis by Formulation (Oral, Parenteral) Secondary Packaging (Cartoning, Labelling) End-of-Line Packaging (Palletizing, Case Packaging)- Global Forecast to 2031" published by Meticulous Research®
read more
Hi-Tech Pharmaceuticals adds two more powder lines to handle the increase in its Precision Protein® and growth in its private label sector.
read more
RxConnected introduces affordable prices on critical prescription medications to assist Americans with the high cost of treatment. RxConnected's intuitive online platform and quick delivery make filling a prescription easy and economical.
read more
Amberen®, a leading brand in symptom relief innovation supporting all phases of menopause, announced today the launch of Amberen ENERGY MOOD SLEEP gummies, a dietary supplement formulated to address symptoms triggered by hormonal changes occurring during perimenopause and menopause.
read more